Can 3M Navigate Legal Risks to Sustain Recent Gains?
July 12, 2025 Netflix Stock Analysis: Is the King Still Reigning?
July 11, 2025 The Harsh Truth: Saving Won’t Make You Rich
July 10, 2025 Moving Out of State from Rockville? Start Here
July 10, 2025 Drive Like Royalty: Best Exotic Cars to Rent in Monaco in 2025
July 10, 2025 2025 Altseason: The Next Frontier in Crypto Growth
BridgeBio Pharma (BBIO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: July 19, 2025 (16:45)
Sector: HealthcareThe share price of BridgeBio Pharma, Inc. (BBIO) now
Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2025, 2026, 2027. How much will one BridgeBio Pharma share be worth in 2025 - 2027?
When should I take profit in BridgeBio Pharma stock? When should I record a loss on BridgeBio Pharma stock? What are analysts' forecasts for BridgeBio Pharma stock? What is the future of BridgeBio Pharma stock? We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.
Historical and forecast chart of BridgeBio Pharma stock
The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.
Long-term forecasts by years.
BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.
BridgeBio Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul 21 | 47.23 | 46.40 | 48.22 | 3.94 |
| Jul 22 | 47.32 | 46.89 | 47.70 | 1.73 |
| Jul 23 | 46.17 | 45.83 | 46.85 | 2.21 |
| Jul 24 | 45.78 | 45.19 | 46.80 | 3.56 |
| Jul 25 | 46.67 | 46.06 | 47.37 | 2.86 |
| Jul 26 | 46.04 | 45.06 | 46.83 | 3.92 |
| Jul 27 | 46.29 | 45.26 | 46.58 | 2.91 |
| Jul 28 | 45.87 | 45.41 | 46.42 | 2.24 |
| Jul 29 | 45.89 | 45.10 | 46.47 | 3.02 |
| Jul 30 | 46.16 | 45.86 | 46.76 | 1.96 |
| Jul 31 | 45.00 | 44.31 | 45.78 | 3.32 |
| Aug 01 | 44.72 | 44.25 | 44.98 | 1.67 |
| Aug 02 | 44.80 | 43.78 | 45.41 | 3.75 |
| Aug 03 | 45.66 | 45.30 | 45.96 | 1.45 |
| Aug 04 | 45.67 | 45.20 | 46.33 | 2.49 |
| Aug 05 | 46.36 | 46.04 | 46.83 | 1.72 |
| Aug 06 | 47.51 | 46.80 | 48.46 | 3.56 |
| Aug 07 | 46.84 | 46.39 | 47.49 | 2.36 |
| Aug 08 | 46.52 | 45.85 | 47.20 | 2.95 |
| Aug 09 | 46.80 | 45.69 | 47.46 | 3.87 |
| Aug 10 | 46.23 | 45.75 | 47.15 | 3.06 |
| Aug 11 | 45.57 | 44.87 | 46.40 | 3.41 |
| Aug 12 | 46.44 | 46.15 | 47.36 | 2.63 |
| Aug 13 | 47.84 | 46.88 | 48.38 | 3.21 |
| Aug 14 | 47.15 | 46.31 | 48.11 | 3.88 |
| Aug 15 | 48.36 | 47.25 | 49.22 | 4.18 |
| Aug 16 | 48.13 | 47.55 | 48.93 | 2.88 |
| Aug 17 | 48.58 | 48.27 | 49.51 | 2.57 |
| Aug 18 | 47.56 | 47.12 | 48.19 | 2.27 |
| Aug 19 | 46.55 | 45.50 | 47.44 | 4.27 |
BridgeBio Pharma Daily Price Targets
BridgeBio Pharma Stock Forecast 07-21-2025.
Forecast target price for 07-21-2025: $47.23.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.790%.
Pessimistic target level: 46.40
Optimistic target level: 48.22
BridgeBio Pharma Stock Forecast 07-22-2025.
Forecast target price for 07-22-2025: $47.32.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 1.696%.
Pessimistic target level: 46.89
Optimistic target level: 47.70
BridgeBio Pharma Stock Forecast 07-23-2025.
Forecast target price for 07-23-2025: $46.17.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.158%.
Pessimistic target level: 45.83
Optimistic target level: 46.85
BridgeBio Pharma Stock Forecast 07-24-2025.
Forecast target price for 07-24-2025: $45.78.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.434%.
Pessimistic target level: 45.19
Optimistic target level: 46.80
BridgeBio Pharma Stock Forecast 07-25-2025.
Forecast target price for 07-25-2025: $46.67.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.778%.
Pessimistic target level: 46.06
Optimistic target level: 47.37
BridgeBio Pharma Stock Forecast 07-26-2025.
Forecast target price for 07-26-2025: $46.04.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 3.775%.
Pessimistic target level: 45.06
Optimistic target level: 46.83
BBIO (BBIO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 33.05 | 30.54 | 35.40 | 13.73 |
| Aug. | 31.70 | 29.54 | 32.52 | 9.16 |
| Sep. | 32.39 | 30.19 | 34.66 | 12.90 |
| Oct. | 31.55 | 29.44 | 34.08 | 13.61 |
| Nov. | 32.84 | 30.35 | 33.60 | 9.68 |
| Dec. | 31.96 | 30.94 | 33.72 | 8.25 |
BridgeBio Pharma forecast for this year
BridgeBio Pharma Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $33.0513. Pessimistic: $30.54. Optimistic: $35.40
BridgeBio Pharma Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $31.6961. Pessimistic: $29.54. Optimistic: $32.52
BridgeBio Pharma Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $32.3935. Pessimistic: $30.19. Optimistic: $34.66
BridgeBio Pharma Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $31.5512. Pessimistic: $29.44. Optimistic: $34.08
BridgeBio Pharma Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $32.8448. Pessimistic: $30.35. Optimistic: $33.60
BridgeBio Pharma Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $31.958. Pessimistic: $30.94. Optimistic: $33.72
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 32.57 | 31.43 | 34.10 | 7.83 |
| Feb | 34.16 | 33.17 | 35.05 | 5.36 |
| Mar | 33.41 | 30.94 | 35.21 | 12.14 |
| Apr | 31.77 | 29.33 | 32.63 | 10.13 |
| May | 31.71 | 30.82 | 33.90 | 9.07 |
| Jun | 31.61 | 29.97 | 32.82 | 8.67 |
| Jul | 33.07 | 31.18 | 34.66 | 10.02 |
| Aug | 35.94 | 34.58 | 38.50 | 10.18 |
| Sep | 38.07 | 36.81 | 41.11 | 10.46 |
| Oct | 41.64 | 39.02 | 42.60 | 8.41 |
| Nov | 44.52 | 41.13 | 46.03 | 10.64 |
| Dec | 43.32 | 41.67 | 44.48 | 6.33 |
BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 44.57 | 41.14 | 46.89 | 12.26 |
| Feb | 41.76 | 39.51 | 42.72 | 7.53 |
| Mar | 42.64 | 41.32 | 45.11 | 8.41 |
| Apr | 41.40 | 40.29 | 43.89 | 8.21 |
| May | 38.92 | 36.82 | 41.72 | 11.75 |
| Jun | 36.97 | 35.35 | 39.52 | 10.57 |
| Jul | 37.34 | 35.92 | 39.14 | 8.21 |
| Aug | 38.87 | 36.78 | 40.90 | 10.08 |
| Sep | 41.01 | 39.50 | 43.02 | 8.20 |
| Oct | 41.59 | 40.26 | 42.54 | 5.38 |
| Nov | 38.30 | 35.43 | 40.94 | 13.47 |
| Dec | 37.80 | 36.37 | 40.37 | 9.93 |
BridgeBio Pharma information and performance
421 KIPLING STREET, PALO ALTO, CA, US
Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BBIO shares in the company outstanding by the market price of one share.
EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about BridgeBio Pharma Stock)
Should I Buy BridgeBio Pharma Shares in 2025 year?
Does BridgeBio Pharma pay dividends?
Which economic sector do BridgeBio Pharma's shares belong to?
Which other securities belong to the same sector as BridgeBio Pharma's shares?
